BBGBloomberg·2dBusiness
score-0.20
Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says
Original
Denmark’s Leo Pharma Delays IPO Plans Beyond 2026, CEO Says
“Reports a corporate timeline delay with a neutral tone, implying slight caution or missed opportunity rather than crisis.”